<DOC>
	<DOCNO>NCT00662467</DOCNO>
	<brief_summary>Following severe heart attack involve front wall heart ( anterior myocardial infarction ) , patient risk develop blood clot main pump chamber cause stroke . In past , study show blood thinner ( warfarin ) decrease risk stroke clot formation administer patient anterior myocardial infarction . However , today 's current practice , certain heart attack patient commonly treat two blood-thinning medication ( aspirin clopidogrel ) prevent recurrent heart attack . Thus , clinical problem create physician clear treat patient anterior myocardial infarction risk clot require aspirin clopidogrel keep blood vessel open . Adding warfarin combination aspirin clopidogrel possibly decrease risk stroke increase risk bleed . Currently , good evidence help guide physician . As demonstrated survey do Hamilton Health Sciences , fifty/fifty split physician use dual ( aspirin clopidogrel ) versus triple ( aspirin , clopidogrel , warfarin ) therapy treatment similar patient describe . The purpose study address bleed stroke complication patient severe anterior myocardial infarction . Half eligible patient receive dual therapy half receive triple therapy . We compare incidence stroke , blood clot , bleed complication two group 3 month .</brief_summary>
	<brief_title>Warfarin After Anterior ST-Elevation Myocardial Infarction</brief_title>
	<detailed_description>Rationale : Left ventricular mural thrombus ( LVT ) remain common complication anterior ST-elevation myocardial infarction ( STEMI ) report incidence range 12- 17 % . Previous study pre-thrombolytic era show warfarin therapy significantly reduce incidence LVT embolic event patient post anterior STEMI . However , risk/benefit ratio warfarin therapy set early revascularization dual antiplatelet therapy aspirin clopidogrel remain unknown . Purpose : To compare incidence death , MI , stroke , embolic event , LVT , bleed complication 3 month patient anterior STEMI ejection fraction le 40 % treat ASA clopidogrel alone versus treat aspirin , clopidogrel , warfarin ( triple therapy group ) . Sample Size : This pilot project help establish feasibility conduct full scale externally fund study . As sample size calculation applicable . The primary aim study determine safety feasibility conduct large-scale trial , pilot project expect reveal statistically significant difference 2 group . Design/Methodology : All patient randomize either aspirin clopidogrel alone triple therapy aspirin , clopidogrel warfarin . The randomization process centralize computer generate . Patients clear indication oral anticoagulation atrial fibrillation , LV thrombus , mechanical heart valve , DVT/PE undergo randomization follow part registry patient triple therapy . All patient remain allocated therapy 3 month time outcome determine . Study intervention : Patients treat either ASA clopidogrel alone ( dual therapy ) aspirin , clopidogrel warfarin ( triple therapy ) combination 3 month . Patients triple therapy arm bridge intravenous unfractionated heparin , low molecular weight heparin , fondaparinux INR therapeutic , follow thrombosis service duration study .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Anterior STEMI An ejection fraction le 40 % per initial LV angiography echocardiogram Randomization possible within hospital admission anticoagulated interruption &gt; 24 hour Patient able willing give inform consent participate trial history intracranial hemorrhage history GI bleed last 6 month hemoglobin &lt; 90 g/L platelet count &lt; 100 x 10exp9/L ischemic stroke last 30 day intracranial tumor aneurysm significant pericardial effusion severe renal failure ( creatinine &gt; 250 mmol/L ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Hemorrhage</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Warfarin</keyword>
</DOC>